OPXS' Q2 Earnings Down Y/Y Amid Delayed Contract Awards
Optex Systems posts year-over-year declines in fiscal Q2 earnings per share and revenues due to delayed government contract awards, though gross margins improve through pricing gains and operational efficiencies.
Zacks·3d ago
More News
The Zacks Analyst Blog UnitedHealth, Merck & Co., Qualcomm, EVI and Optex
UNH, MRK and QCOM drew focus as analysts highlighted growth drivers, pipeline strength and expanding AI and automotive opportunities.
Zacks·9d ago
Top Research Reports for UnitedHealth, Merck & Qualcomm
UnitedHealth, Merck and QUALCOMM lead Zacks' top research picks as analysts highlight growth drivers, earnings trends and key risks.
Zacks·10d ago
Optex Systems (NASDAQ:OPXS) Raised to Strong-Buy at Freedom Capital
Freedom Capital upgraded Optex Systems to a "strong-buy" rating in a report on Monday...
MarketBeat·1mo ago
Optex Systems (NASDAQ:OPXS) Shares Up 3% - Time to Buy?
Optex Systems (NASDAQ:OPXS) Stock Price Up 3% - Time to Buy...
MarketBeat·2mo ago
Optex Systems (NASDAQ:OPXS) Stock Price Up 6.2% - Time to Buy?
Optex Systems (NASDAQ:OPXS) Trading Up 6.2% - Here's What Happened...
MarketBeat·2mo ago
OPXS Skyrockets 140% in a Year: Should You Buy the Stock?
Optex Systems is benefiting from rising defense demand, strong contractor relationships, and a growing backlog, positioning it to capitalize on military modernization and optical systems upgrades.
Zacks·3mo ago
SIFCO Stock Surges 109.7% in Three Months: What's Behind the Rally?
SIF is riding a sharp rally as a return to profitability, stronger margins and rising aerospace demand lift investor sentiment.
Zacks·3mo ago
The Zacks Analyst Blog UnitedHealth, Honeywell , Shopify and Optex Systems
UNH, HON and SHOP land fresh Zacks reports, spotlighting earnings beats, margin pressures and segment strength shaping their outlook.
Zacks·3mo ago
Top Stock Reports for UnitedHealth, Honeywell & Shopify
UnitedHealth's earnings beat highlights steady Optum-driven growth, even as rising medical costs and debt pressures keep valuation concerns in focus.